TY - JOUR
T1 - Effect of posterolateral left ventricular scar on mortality and morbidity following cardiac resynchronization therapy.
AU - Chalil, S
AU - Stegemann, B
AU - Muhyaldeen, SA
AU - Khadjooi, K
AU - Foley, PW
AU - Smith, RE
AU - Leyva, F
PY - 2007/10
Y1 - 2007/10
N2 - Objectives: To determine the effect of a posterolateral (PL) left ventricular scar on mortality and morbidity following cardiac resynchronization therapy (CRT).
Methods: Sixty‐two patients with heart failure (age 67.3 ± 9.6 yrs [mean ± SD], 45 males, New York Heart Association class [NYHA] class III or IV, left ventricular ejection fraction [LVEF]= 35%, left bundle branch block, QRS ≥ 120 ms) underwent late gadolinium enhancement cardiovascular magnetic resonance (LGE‐CMR) for scar imaging. Patients were followed up for 741 (75–1602) days (mean [range]).
Results: The presence of a PL scar emerged as an independent predictor of the composite endpoint of cardiovascular death or hospitalization for worsening heart failure (HR: 3.06 [1.63, 7.7, P < 0.0001]) as well as the endpoint of cardiovascular death (HR: 2.63 [1.39, 6.65], P = 0.0016). A transmural PL scar was the strongest predictor of these endpoints (both P < 0.0001). The symptomatic responder rate (improvement by ≥1 NYHA classes or ≥25% in 6‐min walking distance) was 83% in the group with non‐PL scars, but only 47% in the group with transmural PL scars (P < 0.0001). Pacing over the scar was associated with a higher mortality and morbidity than pacing outside the scar (all P < 0.05).
Conclusions: A PL scar is associated with a worse clinical outcome following CRT, particularly if it is transmural. Pacing scarred left ventricular myocardium carries a greater risk of mortality and morbidity than pacing nonscarred myocardium.
AB - Objectives: To determine the effect of a posterolateral (PL) left ventricular scar on mortality and morbidity following cardiac resynchronization therapy (CRT).
Methods: Sixty‐two patients with heart failure (age 67.3 ± 9.6 yrs [mean ± SD], 45 males, New York Heart Association class [NYHA] class III or IV, left ventricular ejection fraction [LVEF]= 35%, left bundle branch block, QRS ≥ 120 ms) underwent late gadolinium enhancement cardiovascular magnetic resonance (LGE‐CMR) for scar imaging. Patients were followed up for 741 (75–1602) days (mean [range]).
Results: The presence of a PL scar emerged as an independent predictor of the composite endpoint of cardiovascular death or hospitalization for worsening heart failure (HR: 3.06 [1.63, 7.7, P < 0.0001]) as well as the endpoint of cardiovascular death (HR: 2.63 [1.39, 6.65], P = 0.0016). A transmural PL scar was the strongest predictor of these endpoints (both P < 0.0001). The symptomatic responder rate (improvement by ≥1 NYHA classes or ≥25% in 6‐min walking distance) was 83% in the group with non‐PL scars, but only 47% in the group with transmural PL scars (P < 0.0001). Pacing over the scar was associated with a higher mortality and morbidity than pacing outside the scar (all P < 0.05).
Conclusions: A PL scar is associated with a worse clinical outcome following CRT, particularly if it is transmural. Pacing scarred left ventricular myocardium carries a greater risk of mortality and morbidity than pacing nonscarred myocardium.
UR - http://europepmc.org/abstract/med/17897122
UR - https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1540-8159.2007.00841.x
U2 - 10.1111/j.1540-8159.2007.00841.x
DO - 10.1111/j.1540-8159.2007.00841.x
M3 - Article
C2 - 17897122
SN - 0147-8389
VL - 30
SP - 1201
EP - 1209
JO - Pacing and Clinical Electrophysiology
JF - Pacing and Clinical Electrophysiology
IS - 10
ER -